Researchers at the Francis Crick Institute, King's College London and the University of Fribourg have developed polymer water ...

Xcellbio announced today that it had granted bluebird bio, Inc., a commercial license and entered into a supply agreement for the use of Xcellbio’s proprietary cell manufacturing technology, AVATAR™, ...

Cellares' forward momentum continues, as the company announced April 1, 2025, a notable milestone for its Cell Shuttle.

The AI server boom is pushing manufacturers to transform how they design and build high-performance hardware systems.

We are proud to have been chosen as the exclusive supplier for this critical hydrogen application,” said Markus Rettig, sales ...

The roots of palletized cell controller systems have remained similar in nature for quite some time in terms of functionality and optimizing cell throughput. Most provide for scheduling what pallet ...

The second edition of The Asia Manufacturing Index by Dezan Shira & Associates is now out. The 2025 index provides essential insights into Asia’s dynamic industrial landscape, ranking eleven countries ...

These results clearly demonstrate that hybrid optimization enables designers to attain performance targets beyond that achievable by gate-/cell-level optimization tools alone. Introduction Digital ...

In this study, we aim to enhance CAR-T cell function by focusing on the solely transmembrane domain design. Methods: Utilizing plasmid construction and lentivirus generation, we get two different ...

By examining how these parameters are controlled in specific cell biological examples we can identify a handful of simple design principles that seem to underlie cellular architecture and assembly.

What Is B-Cell Lymphoma? B-cell lymphoma is a cancer that forms in your white blood cells called lymphocytes. These cells are made by your lymphatic system, which plays an important role in immunity.

Cell therapies based on chimeric antigen receptors (CARs) have emerged as promising approaches for blood cancers. However, current CAR-T treatments suffer from on-target, off-tumor toxicity, because ...